Biologics

Richard Kim, MD, is using stem cells to help relieve patient pain at his private practice in Saratoga Springs, N.Y.

Ortho Regenerative Technologies reported a successful pre-investigational drug meeting with the FDA in February and is now preparing for its rotator cuff phase I/II clinical trial.

In July, orthobiologics company Biogennix hit its best ever month for sales since its formation in 2009.

Biofirma, a subsidiary of IMAC Holdings, received "registered" status by the FDA.

A study published in Stem Cells Translational Medicine found that an injection of human amniotic fluid stem cells can be used to protect the spinal cord of a fetus from myelomeningocele.

John Tierney, DO, used Anika Therapeutics' injectable hyaluronic acid-based bone repair product in a patient.

Bioventus plans to expand Durolane, its hyaluronic acid joint-fluid osteoarthritis injection, into Australia and New Zealand.

Daniel Penello, MD, of Alexander Orthopaedic Associates in St. Petersburg, Fla., is a fellowship-trained orthopedic surgeon who specializes in hand and upper extremity surgery.

A group of orthobiologics experts established a Delphi panel process to set treatment standards for an outpatient stem cell procedure known as bone marrow concentrate.

PTC Therapeutics is leasing a 185,000-square-foot biologics-focused research space from Bristol-Myers Squibb, BioPharmaReport.com reports.